April 8, 2022 – Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who ...
April 6, 2022 – Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
April 6, 2022 – Myocarditis (inflammation of the heart muscle) is usually caused by viruses, such as in Covid-19 disease ...
April 4, 2022 – Staying well-hydrated may be associated with a reduced risk for developing heart failure, according to ...
April 4, 2022 – Observational research has suggested that light alcohol consumption may provide heart-related health ...
April 4, 2022 – Deep in the brain a group of large neurons produce a hormone which prompts our bodies to hold onto more ...
April 4, 2022 – Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart ...
April 3, 2022 — egnite, Inc., an advanced technology digital health company focused on providing artificial intelligence ...
April 3, 2022 — A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath ...
April 3, 2022 — Silence Therapeutics, a leader in the discovery, development and delivery of novel short interfering ...
April 1, 2022 — A new joint guideline published today from the American College of Cardiology, the American Heart ...
April 1, 2022 – The activation of the bone marrow appears to play a key role in the origin and development of ...
April 1, 2022 — Royal Philips, a global leader in health technology, announced new additions to its innovative ...
Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March ...